About Satyadeva Pharmaceuticals
Satyadeva Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2001. It manufactures pharmaceutical intermediates and provides contract manufacturing services globally. It operates on a B2B model. The company has 149 employees. Its Indian entity Satyadeva Pharmaceuticals Private Limited reported revenue of ₹103 Cr. Satyadeva Pharmaceuticals offers products and services including ARV Intermediates and Chemical Compounds. Its focus areas include Pharmaceuticals, Drug Manufacturing, Intermediates and Research and Development. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Satyadeva Pharmaceuticals is a US FDA approved and ISO certified company based in India, specializing in the production of pharmaceutical intermediates, particularly for anti-retroviral drugs. It operates through contract manufacturing, research and development, and quality control processes to ensure high standards. The company serves international and domestic customers with a focus on ethical practices, environmental safety, and continual improvement in quality management. Its facilities are located in Hyderabad and Pashamylaram, supporting global health initiatives through reliable manufacturing.
- Headquarters Hyderabad, India
- Employees 149
- SectorsHealthcare
- Phone•••• ••••
- Website satyadevapharma.com
- Legal Name Satyadeva Pharmaceuticals Private Limited
- Date of Incorporation 11 Aug, 2000
- Jurisdiction Medak, Telangana, India
- Annual Revenue₹103 Cr
FY 2025 · +5% YoY
- Net Profit₹3.10 Cr
FY 2025 · 3% margin
- EBITDA₹8.01 Cr
FY 2025 · 8% margin
- Employee Count149
Associated legal entities of Satyadeva Pharmaceuticals
Satyadeva Pharmaceuticals operates through Satyadeva Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Satyadeva Pharmaceuticals Private Limited CIN U24239TG2000PTC035107 | Active | 11 Aug 2000 | Medak, Telangana | ₹103 Cr | 149 | 5 | View details |
Products & Services of Satyadeva Pharmaceuticals
Satyadeva Pharmaceuticals offers a comprehensive portfolio of products and services, including ARV Intermediates and Chemical Compounds.
Manufactures intermediates for anti-retroviral drugs to support global health.
Produces various chemical intermediates listed by CAS numbers for manufacturing.
Board of directors of Satyadeva Pharmaceuticals Private Limited (Satyadeva Pharmaceuticals)
Satyadeva Pharmaceuticals Private Limited is the primary company behind Satyadeva Pharmaceuticals. The board of Satyadeva Pharmaceuticals Private Limited currently have 5 directors; the longest-serving is Eswara Narayana Kosaraju, appointed in 2000. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Eswara Narayana Kosaraju DIN 00430474 | Managing Director | 11 Aug 2000 | 26 yrs 2 mo | Satyadeva Pharmaceuticals Private Limited |
| Srinivasa Rao Tubati DIN 00430483 | Whole-time director | 21 Jul 2005 | 21 yrs 3 mo | Satyadeva Pharmaceuticals Private Limited |
| Venkata Prasad Averineni DIN 00430498 | Whole-time director | 21 Jul 2005 | 21 yrs 3 mo | Satyadeva Pharmaceuticals Private Limited |
| Swathi Nandamuri DIN 02322351 | Director | 01 Apr 2019 | 7 yrs 6 mo | Satyadeva Pharmaceuticals Private Limited |
| Hari Krishna Kosaraju DIN 00942606 | Director | 01 Apr 2019 | 7 yrs 6 mo | Satyadeva Pharmaceuticals Private Limited |
Financials of Satyadeva Pharmaceuticals
Figures of Satyadeva Pharmaceuticals Private Limited, the primary company behind Satyadeva Pharmaceuticals, for FY 2025. Revenue was ₹103 Cr (+5% year on year). Net profit was ₹3.10 Cr (3% margin). EBITDA was ₹8.01 Cr (8% margin). Revenue has grown at a compounded annual rate of -4% over three years and -19% over five years.
- ₹103 CrRevenue · FY 2025 · +5% YoY
- ₹3.10 CrNet profit · 3% margin
- ₹8.01 CrEBITDA · 8% margin
- ₹2.00 CrPaid-up capital
- 149Employees (provident fund records)
- -4%Revenue CAGR, 3 years
- -19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Satyadeva Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Satyadeva Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Satyadeva Pharmaceuticals
Satyadeva Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Satyadeva Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Satyadeva Pharmaceuticals
Satyadeva Pharmaceuticals was founded in 2001.
Satyadeva Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Satyadeva Pharmaceuticals has 149 employees.
The primary company behind Satyadeva Pharmaceuticals, Satyadeva Pharmaceuticals Private Limited, reported revenue of ₹103 Cr for FY 2025, up 5% year on year.
Satyadeva Pharmaceuticals is a US FDA approved and ISO certified company based in India, specializing in the production of pharmaceutical intermediates, particularly for anti-retroviral drugs. It operates through contract manufacturing, research and development, and quality control processes to ensure high standards. The company serves international and domestic customers with a focus on ethical practices, environmental safety, and continual improvement in quality management. Its facilities are located in Hyderabad and Pashamylaram, supporting global health initiatives through reliable manufacturing.
Satyadeva Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and SeQuent.
Satyadeva Pharmaceuticals offers ARV Intermediates and Chemical Compounds.
Satyadeva Pharmaceuticals operates through Satyadeva Pharmaceuticals Private Limited.
The legal entities of Satyadeva Pharmaceuticals currently have 5 directors, including Srinivasa Rao Tubati, Venkata Prasad Averineni, Swathi Nandamuri and others.